Search Within

Viktoriya Paroder

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (7)
  3. Review (1)
Groups
  1. Body Imaging Service (17)
  2. Department of Medicine (17)
  3. Hematologic Malignancies, Division of (17)
  4. Radiology, Department of (17)
  5. Solid Tumor Oncology Division (17)
  6. Gastrointestinal Oncology Service (13)

More Groups

People
  1. Geoffrey Ku (10)
  2. Marinela Capanu (7)
  3. Steven Maron (7)
  4. Yelena Janjigian (7)
  5. Joanne Chou (6)
  6. David Ilson (5)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (2)
Publications
  1. Journal of Clinical Oncology (6)
  2. American Journal of Roentgenology (2)
  3. Journal of Gastrointestinal Oncology (2)
  4. Annals of Oncology (1)
  5. Cancer Research (1)
  6. Cancers (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (2)
  3. American Roentgen Ray Society (2)
  4. Pioneer Bioscience Publishing Company (2)
  5. Cell Press (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction
    Journal Article

    Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
    American Journal of Roentgenology (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Congenital cardiac liver cirrhosis with combined hepatocellular-cholangiocarcinoma- A case report
    Journal Article

    El Dika, I.; Shia, J.; Chen, C. L.; Paroder, V.; Carver, A.; Shamseddine, A.; Mukherji, D.; Sirohi, B.; Makondi, P. T.; Asseily, C.; more...
    Journal of Gastrointestinal Oncology (2022)

    Fulltext@MSK | Save
  • Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
    Meeting Abstract

    Cytryn, S.; Joshi, S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; Rao, D.; Goldberg, Z.; Sugarman, R.; Antoine, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
    Journal Article

    Su, W.; Mukherjee, R.; Yaeger, R.; Son, J.; Xu, J.; Na, N.; Timaul, N. M.; Hechtman, J.; Paroder, V.; Lin, M.; more...
    Molecular Cell (2022)

    Fulltext@MSK | Save
  • Can (18)F-FDG PET/CT radiomics features predict clinical outcomes in patients with locally advanced esophageal squamous cell carcinoma?
    Journal Article

    Jayaprakasam, V. S.; Gibbs, P.; Gangai, N.; Bajwa, R.; Sosa, R. E.; Yeh, R.; Greally, M.; Ku, G. Y.; Gollub, M. J.; Paroder, V.
    Cancers (2022)

    Fulltext@MSK | Save